Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab

Thromb Haemost. 2008 Jul;100(1):151-3. doi: 10.1160/TH08-02-0089.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • ADAM Proteins / immunology
  • ADAMTS13 Protein
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies / blood
  • Blood Component Transfusion*
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Platelet Count
  • Purpura, Thrombotic Thrombocytopenic / drug therapy
  • Purpura, Thrombotic Thrombocytopenic / enzymology
  • Purpura, Thrombotic Thrombocytopenic / immunology
  • Purpura, Thrombotic Thrombocytopenic / therapy*
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Glucocorticoids
  • Immunosuppressive Agents
  • Rituximab
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human